Glenmark Pharmaceuticals Limited (GLENMARK.NS) NSE

2,015.40

-31.59998(-1.54%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap425.88B
Enterprise Value433.85B
P/E Ratio75.5
PEG Ratio-2.69
Price/Sales Ratio4.27
Price/Book Ratio6.43
Enterprise/Revenue4.27
Enterprise/EBITDA29.48

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.24

Management Effectiveness

Return On Assets0
Return On Equity0.09

Income Statement

Revenue133.63B
Revenue/Share471.49
Gross Profit88.38B
EBITDA21.68B
Net Income10.47B
Diluted EPS37.11

Balance Sheet

Total Cash29.58B
Total Cash/Share0
Total Debt12.24B
Total Debt/Equity0
Current Ratio0
Book Value Per Share313.4

Price History

52-Week Change31.23
52-Week High2,284.8
52-Week Low1,275.5
Moving Average 50 Days1,900.43
Moving Average 200 Days1,794.71

Statistics

Average Volume812,476
Shares Outstanding282.2M
% Held by Institutions0.05

Dividend And Splits

Trailing Annual Dividend Rate5
Trailing Annual Dividend Yield0.25
Payout Ratio0
Last Split Factor2:1
Last Split DateSeptember 10, 2007